65.67USD-1.36%Mkt Cap: 12.78B USDP/E: —Last update: 2026-06-01
BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases. The company offers Attruby, a next-generation oral small molecule near-complete TTR sta…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.78B USD
Enterprise Value14.54B USD
Revenue (TTM)579.96M USD
Gross Profit481.11M USD
Net Income (TTM)-724.93M USD
Revenue/Share3.010 USD
Last Price65.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees834
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS10806X1028
Valuation
P/E (Trailing)—
P/E (Forward)199.92
PEG—
EV/EBITDA-29.14
EV/Revenue25.07
P/S22.38
P/B-6.19
EPS (TTM)-3.74
EPS (Forward)0.33
52W Range
32.3763% of range84.94
52W High84.94 USD
52W Low32.37 USD
Profitability
Gross Margin95.82%
Oper. Margin-54.47%
EBITDA Margin-86.02%
Profit Margin-144.39%
ROE34.74%
ROA-77.45%
Growth
Revenue Growth66.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-445.91M USD
CapEx (TTM)9.59M USD
FCF Margin-54.82%
FCF Yield-2.49%
Net Debt1.55B USD
Net Debt/EBITDA-3.11
Balance Sheet
Debt/Equity-0.89
Current Ratio1.52
Quick Ratio1.40
Book Value/Sh-10.7130 USD
Cash/Share4.800 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)102.65 USD
Target Range76.00 USD – 157.00 USD
# Analysts22
Ownership
Shares Out.195.86M
Float162.96M
Insiders3.90%
Institutions102.54%
Short Interest
Short Ratio8.2d
Short % Float13.77%
Short % Out.12.34%
Shares Short24.16M
Short (prev mo.)22.68M
Technical
SMA 5071.05 (-7.6%)
SMA 20066.29 (-0.9%)
Beta1.02
S&P 52W Chg27.94%
Avg Vol (30d)2.94M
Avg Vol (10d)2.51M
Technical Indicators
RSI (14)44.1
MACD-1.0497
MACD Signal-1.1916
MACD Hist.+0.1418
BB Upper70.61 USD
BB Middle67.59 USD
BB Lower64.57 USD
BB Width8.92%
ATR (14)3.104 USD
Vol Ratio (20d)0.59x